Iterum Therapeutics plc (ITRM) News https://ir.iterumtx.com/sec-filings-email/rss Iterum Therapeutics plc (ITRM) - SEC Filings en-us Equisolve Investor Relations Suite https://d1io3yog0oux5.cloudfront.net/iterumtx/files/iterum-logo.png https://www.iterumtx.com <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1066-0001193125-26-133247 Tue, 31 Mar 26 07:00:41 -0400 https://ir.iterumtx.com/sec-filings-email?page=1#document-1066-0001193125-26-133247 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1065-0001193125-26-127785 Fri, 27 Mar 26 09:21:31 -0400 https://ir.iterumtx.com/sec-filings-email?page=1#document-1065-0001193125-26-127785 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1063-0001193125-26-088494 Tue, 03 Mar 26 16:47:31 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1063-0001193125-26-088494 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1062-0001193125-26-085646 Mon, 02 Mar 26 17:09:30 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1062-0001193125-26-085646 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1061-0001193125-26-057393 Wed, 18 Feb 26 17:06:36 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1061-0001193125-26-057393 <![CDATA[ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1060-0001193125-26-051546 Fri, 13 Feb 26 16:37:12 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1060-0001193125-26-051546 <![CDATA[ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1059-0001193125-26-022666 Mon, 26 Jan 26 16:30:34 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1059-0001193125-26-022666 <![CDATA[ DEF 14A - Definitive proxy statements ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1058-0001193125-26-001078 Fri, 02 Jan 26 17:15:29 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1058-0001193125-26-001078 <![CDATA[ PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1057-0001193125-25-331139 Tue, 23 Dec 25 17:15:47 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1057-0001193125-25-331139 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=1#document-1056-0001193125-25-317728 Fri, 12 Dec 25 17:01:15 -0500 https://ir.iterumtx.com/sec-filings-email?page=1#document-1056-0001193125-25-317728 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1055-0001193125-25-288848 Thu, 20 Nov 25 07:01:40 -0500 https://ir.iterumtx.com/sec-filings-email?page=2#document-1055-0001193125-25-288848 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1054-0001193125-25-281557 Fri, 14 Nov 25 07:31:40 -0500 https://ir.iterumtx.com/sec-filings-email?page=2#document-1054-0001193125-25-281557 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1048-0001193125-25-281531 Fri, 14 Nov 25 07:15:49 -0500 https://ir.iterumtx.com/sec-filings-email?page=2#document-1048-0001193125-25-281531 <![CDATA[ 8-K - Current report ]]> 8-K, EX-5.1 ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1046-0001193125-25-241556 Thu, 16 Oct 25 17:19:13 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1046-0001193125-25-241556 <![CDATA[ 424B5 - Prospectus [Rule 424(b)(5)] ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1044-0001193125-25-241550 Thu, 16 Oct 25 17:17:10 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1044-0001193125-25-241550 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1043-0000950170-25-113986 Wed, 10 Sep 25 16:16:01 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1043-0000950170-25-113986 <![CDATA[ 8-K - Current report ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1042-0000950170-25-111974 Thu, 28 Aug 25 16:31:07 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1042-0000950170-25-111974 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1041-0000950170-25-110370 Wed, 20 Aug 25 08:15:54 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1041-0000950170-25-110370 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1039-0000950170-25-106908 Tue, 12 Aug 25 07:00:31 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1039-0000950170-25-106908 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-10.1, EX-10.2, EX-10.3, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.iterumtx.com/sec-filings-email?page=2#document-1038-0000950170-25-102400 Tue, 05 Aug 25 07:31:34 -0400 https://ir.iterumtx.com/sec-filings-email?page=2#document-1038-0000950170-25-102400